Aggressive brain tumors, specifically glioblastomas, have been found to contain a distinct population of immune cells, myeloid-derived suppressor cells (MDSCs), that support tumor growth.

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia 30332, United States School of Electrical & Computer ...

Department of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington, 3720 15th Avenue NE, Box 355061, Seattle, Washington 98195, United States Seattle Children’s ...

Objective To determine the impact of ultrasound (US) intrinsic limitation to assess aortitis versus FDG-PET/CT in patients with US-proven giant cell arteritis (GCA) and to identify factors associated ...

Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

Recent research has focused on the detection in peripheral blood of rare circulating tumor cells (CTCs), which serve as noninvasive markers that can help inform diagnoses. It is inherently ...

This is because the primary tumor continuously releases cancer cells into the blood. These circulating tumor cells (CTCs) can join together into small clusters of up to a dozen cells and settle in ...

Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for ... Within cancerous tumours, there are special cells, called tumour-propagating cells, that drive tumour ...

The active ingredient digoxin, a substance found in foxglove, reduces the number of cells in clusters of breast cancer cells circulating in the blood. These clusters are responsible for the formation ...

and cancer cells, providing insights into how fibroblast activation can influence tumor progression. The model opens up new possibilities for studying fibroblast-driven effects in diverse settings, ...